発現ベクターの世界市場2022-2028:ホスト種類別、用途別、エンドユーザー別、地域別

【英語タイトル】Global Expression Vectors Market Size study, By Host Type (Bacterial Expression Vectors, Mammalian Expression Vectors, Insect Expression Vectors, Yeast Expression Vectors, Other Expression Vectors), By Application (Therapeutic Applications, Research Applications, Industrial Applications), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), Academic Research Institutes, Other End Users), and Regional Forecasts 2022-2028

Bizwit Research & Consultingが出版した調査資料(BZW22MY349)・商品コード:BZW22MY349
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2022年4月
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Bizwit Research社は、世界の発現ベクター市場規模が2021年334.54百万ドルに達し、2022年から2028年までに5.5%成長すると予想しています。本市場調査レポートでは、発現ベクターの世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、ホスト種類別(細菌発現ベクター、哺乳類発現ベクター、昆虫発現ベクター、酵母発現ベクター、その他)分析、用途別(治療用、研究用、工業用)分析、エンドユーザー別(製薬・バイオテクノロジー企業、医薬品開発業務受託機関(CRO)・医薬品製造受託機関(CMO)、学術研究機関、その他)分析、地域別分析、競争分析、調査プロセスなどの項目を掲載しています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界の発現ベクター市場規模:ホスト種類別(細菌発現ベクター、哺乳類発現ベクター、昆虫発現ベクター、酵母発現ベクター、その他)
・世界の発現ベクター市場規模:用途別(治療用、研究用、工業用)
・世界の発現ベクター市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、医薬品開発業務受託機関(CRO)・医薬品製造受託機関(CMO)、学術研究機関、その他)
・世界の発現ベクター市場規模:地域別
・競争分析
・調査プロセス
【レポートの概要】

Global Expression Vectors Market is valued approximately USD 334.54 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2022-2028.

An expression vector is also generally called as an expression construct that is a virus or plasmid planned for gene expression in cells. This vector is mainly used to introduce a particular gene into a target cell and can seize the cell’s mechanism for protein synthesis to create the protein encoded by the gene. The growing demand for protein-based drugs, rising prevalence of lifestyle diseases, infectious diseases, and genetic disorders, technological developments, coupled with the increased funding for protein research are the primary factors that are fostering market growth across the globe.

For instance, as per the national cancer institute, cancer is the leading cause of death around the world. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths occurred globally. Also, by 2040, the number of new cancer cases per year is likely to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Therefore, rising incidences of lifestyle diseases like cancer, cardiovascular diseases, diabetes, and many others are anticipated to bolster the demand for the expression vector, which, in turn, impels market growth. However, increasing competition among the market players and the high cost of protein therapy impede the growth of the market over the forecast period of 2022-2028. Also, rising investments in the R&D activities and development of the emerging market are anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the Global Expression Vectors Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to rising investment by the public and private companies in biology research and emergence of the novel technologies in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing awareness for the availability of biologics and development of the healthcare infrastructure, and growth of the emerging economies such as India and China would create lucrative growth prospects for the Expression Vectors market across the Asia-Pacific region.

Major market players included in this report are:
Thermo Fisher Scientific, Inc.
Promega Corporation
Sigma-Aldrich Corporation
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
New England Biolabs Inc.
Merck Millipore
QIAGEN N.V.
Clontech Laboratories, Inc.
ATUM
GenScript USA Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Host Type:
Bacterial Expression Vectors
Mammalian Expression Vectors
Insect Expression Vectors
Yeast Expression Vectors
Other Expression Vectors

By Application:
Therapeutic Applications
Research Applications
Industrial Applications

By End User:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
Academic Research Institutes
Other End Users

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019. 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Expression Vectors Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Global Expression Vectors Market, by Region, 2020-2028 (USD Million)
1.2.2. Global Expression Vectors Market, by Host Type, 2020-2028 (USD Million)
1.2.3. Global Expression Vectors Market, by Application, 2020-2028 (USD Million)
1.2.4. Global Expression Vectors Market, by End User, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Expression Vectors Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Expression Vectors Market Dynamics
3.1. Expression Vectors Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence rate of infectious diseases, lifestyle diseases, and genetic disorders
3.1.1.2. Increasing demand of protein-based drugs (biologics)
3.1.2. Market Challenges
3.1.2.1. Increasing competition among the Market players
3.1.2.2. High cost of protein therapy
3.1.3. Market Opportunities
3.1.3.1. Rising investments in the R&D activities
3.1.3.2. Development of the emerging Market
Chapter 4. Global Expression Vectors Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Expression Vectors Market, by Host Type
6.1. Market Snapshot
6.2. Global Expression Vectors Market by Host Type, Performance – Potential Analysis
6.3. Global Expression Vectors Market Estimates & Forecasts by Host Type 2018-2028 (USD Million)
6.4. Expression Vectors Market, Sub Segment Analysis
6.4.1. Bacterial Expression Vectors
6.4.2. Mammalian Expression Vectors
6.4.3. Insect Expression Vectors
6.4.4. Yeast Expression Vectors
6.4.5. Other Expression Vectors
Chapter 7. Global Expression Vectors Market, by Application
7.1. Market Snapshot
7.2. Global Expression Vectors Market by Application, Performance – Potential Analysis
7.3. Global Expression Vectors Market Estimates & Forecasts by Application 2018-2028 (USD Million)
7.4. Expression Vectors Market, Sub Segment Analysis
7.4.1. Therapeutic Applications
7.4.2. Research Applications
7.4.3. Industrial Applications
Chapter 8. Global Expression Vectors Market, by End User
8.1. Market Snapshot
8.2. Global Expression Vectors Market by End User, Performance – Potential Analysis
8.3. Global Expression Vectors Market Estimates & Forecasts by End User 2018-2028 (USD Million)
8.4. Expression Vectors Market, Sub Segment Analysis
8.4.1. Pharmaceutical and Biotechnology Companies
8.4.2. Contract Research Organization (CROs) and Contract Manufacturing Organization (CMOs)
8.4.3. Academic Research Institutes
8.4.4. Other End Users
Chapter 9. Global Expression Vectors Market, Regional Analysis
9.1. Expression Vectors Market, Regional Market Snapshot
9.2. North America Expression Vectors Market
9.2.1. U.S. Expression Vectors Market
9.2.1.1. Host Type estimates & forecasts, 2018-2028
9.2.1.2. Application estimates & forecasts, 2018-2028
9.2.1.3. End User estimates & forecasts, 2018-2028
9.2.2. Canada Expression Vectors Market
9.3. Europe Expression Vectors Market Snapshot
9.3.1. U.K. Expression Vectors Market
9.3.2. Germany Expression Vectors Market
9.3.3. France Expression Vectors Market
9.3.4. Spain Expression Vectors Market
9.3.5. Italy Expression Vectors Market
9.3.6. Rest of Europe Expression Vectors Market
9.4. Asia-Pacific Expression Vectors Market Snapshot
9.4.1. China Expression Vectors Market
9.4.2. India Expression Vectors Market
9.4.3. Japan Expression Vectors Market
9.4.4. Australia Expression Vectors Market
9.4.5. South Korea Expression Vectors Market
9.4.6. Rest of Asia Pacific Expression Vectors Market
9.5. Latin America Expression Vectors Market Snapshot
9.5.1. Brazil Expression Vectors Market
9.5.2. Mexico Expression Vectors Market
9.6. Rest of The World Expression Vectors Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Promega Corporation
10.2.3. Sigma-Aldrich Corporation
10.2.4. Agilent Technologies Inc.
10.2.5. Bio-Rad Laboratories Inc.
10.2.6. New England Biolabs Inc.
10.2.7. Merck Millipore
10.2.8. QIAGEN N.V.
10.2.9. Clontech Laboratories, Inc.
10.2.10. ATUM
10.2.11. GenScript USA Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption



★調査レポート[発現ベクターの世界市場2022-2028:ホスト種類別、用途別、エンドユーザー別、地域別] (コード:BZW22MY349)販売に関する免責事項を必ずご確認ください。
★調査レポート[発現ベクターの世界市場2022-2028:ホスト種類別、用途別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆